Imclone Systems Is A Biotechnology Company Founded In 1984Now A Wholly Owned Subsidiary Of Eli Lilly And Companyinitially Focused On Drug Discovery For Infectious Diseasesimclone Shifted Its Emphasis To Oncologydeveloping Treatments For Cancerthe Company Is Best Known For Its Product Erbituxcetuximab A Monoclonal Antibody Used In Treating Colorectal And Head And Neck Cancers Imclone S Acquisition By Eli Lilly In 2008 Enhanced Its Capabilities In The Pharmaceutical Industry And Integrated Its Research And Development Efforts Into Lilly S Operationstodayimclone Continues To Contribute To The Development Of Biologic Medicines In Oncology As Part Of Eli Lilly S Broader Portfolio
No conferences found for this company.
| Company Name | Imclone Systems Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
